Indegene empowered a leading global medical device manufacturer to identify opportunities for gastrointestinal (GI) cancer surgical procedures in China. Overcoming limited historical data access, scarce resources for trend analysis, and challenges evaluating promising procedures and market potential across regions, Indegene's analytics software integrated primary and secondary research. It uncovered key market trends, benchmarked procedures, forecasted growth, and pinpointed high-potential opportunities—enabling data-driven strategies, resource optimization, and accelerated expansion in China's GI cancer treatment landscape.

Join for free to read